University of Crete (UOC)
Μελέτη της έκφρασης της αντιαποπτωτικής πρωτεΐνης Bcl-2 στους κυτταρικούς πληθυσμούς του βρογχοκυψελιδικού εκπλύματος ασθενών με ιδιοπαθή πνευμονική ίνωση και σαρκοείδωση
Abstract
dc:descriptionBACKGROUND-AIM. Apoptosis, also known as programmed cell death is a normal procedure at importance in the ''homeostasis'' of multicellular organisms. Apoptotic cellular death probably correlates to the pathophysiologic mechanisms of alveolitis in sarcoidosis and idiopathic pulmonary fibrosis (IPF). Our purpose was to investigate changes in the expression of the antiapoptotic protein bcl-2, one of the most important inhibiting factors of apoptosis, on bronchoalveolar lavage fluid (BALF) cell populations in patients with IPF and sarcoidosis. MATERIALS AND METHODS. Fiberoptic bronchoscopy and BAL was performed in 15 patients with IPF and 13 patients with sarcoidosis (10 patients with stage I and 3 with stage II disease based on chest radiography). None of them was under treatment with corticosteroids or other immunosuppressive agents. For comparison and statistical evaluation of results, 10 normal subjects served as control group (nonsmokers, with normal chest radiography and spirometry). BAL was performed in the area of maximal radiographic shadowing (based on high-resolution computed tomography findings) at patients with IPF and sarcoidosis stage II and in the middle lobe or lingula in cases of stage I sarcoidosis or normal subjects Differential counts of BAL cell types were determined by microscopic observation after staining with Giemsa and Papanikolaou stain. Cellular bcl-2 expression was identified using an immunoperoxidase staining method with monoclonal anti-bcl-2 antibodies. RESULTS A statistically significant (p<0,001) increase in the expression of bcl-2 in BAL neutrophils and eosinophils was observed in patients with IPF compared to controls. BAL macrophages exhibited a slight (statistically insignificant) increase in bcl-2 expression in IPF patients. No bcl-2 expression was observed in BAL lymphocytes from IPF patients in contrast to the control group, where this certain protein was expressed in approximately one third of the cases. Both lymphocytes and macrophages in sarcoid patients' BAL exhibit a significant increase in the expression of bcl-2 compared to control group (p<0,001). On the contrary, no expression of bcl-2 was observed on neutrophils and eosinophils nor in the sarcoid patients group either in the normal volunteer control group. CONCLUSIONS. Our results suggest that the antiapoptotic protein bcl-2 is overexpressed (in statistically significant percentage) on BAL neutrophils and eosinophils in IPF patients and on lymphocytes and macrophages in sarcoid patients, namely the cells that characterise the special cellular profile of each one of these diseases. This finding probably correlates with the pathophysiologic mechanisms of these diseases because apoptosis resistance means prolongation of cellular survival and cellular resistance against factors that promote its functional impairment and consequent destruction. In addition to the information on pathophysiological facts at alveolar level obtained by the study of bcl-2, our data could also prove to be a useful marker of disease activity (IPF or sarcoidosis) and probably it's response to treatment.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mermigkis, Charalampos
- Μερμίγκης, Χαράλαμπος
Subjects
dc:subject × 14- Ιδιοπαθής πνευμονική ίνωση
- Σαρκοείδωση
- Βρογχοκυψελιδικό έκπλυμα
- Απόπτωση (προγραμματισμένος κυτταρικός θάνατος)
- Αντιαποπτωτική πρωτείνη bcl-2
- Idiopathic pulmonary fibrosis (IPF)
- Sarcoidosis
- Bronchoalveolar lavage ( BAL )
- Apoptosis
- Antiapoptotic protein bcl-2
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/15853